News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Reproductive health and male infertility expert crowned ESA Life Member
Internationally renowned male reproductive health expert Professor Rob McLachlan AM has been awarded Life Membership of the Endocrine Society of Australia (ESA).… Read more
-
Untangling the impact of sildenafil on unborn babies
A discovery by Hudson Institute researchers sheds light on the potential reasons why exposing unborn babies affected by fetal growth restriction (FGR) to sildenafil may have led to unexpected neonatal deaths.… Read more
-
Ruby Oberin wins award in recognition of bone disease researcher
Congratulations to Ruby Oberin for winning The Australian and New Zealand Bone and Mineral Society (ANZBMS) 2020 Christopher and Margie Nordin Young Investigator Award.… Read more
-
Menopause researcher Professor Henry Burger AO awarded Lifetime Achievement Award
Congratulations to Professor Henry Burger AO for being awarded the Lifetime Achievement Award for outstanding contribution to menopause, from the International Menopause Society.… Read more
-
Cord clamping and CPR discovery could change practice
Newborn babies who need resuscitating at birth could benefit from CPR while their umbilical cord is still attached, according to new research.… Read more
-
Dr Jun Yang and primary aldosteronism profiled
After watching her father struggle to battle hypertension — or high blood pressure — for decades, Dr Jun Yang ran some tests and was able to find one targeted treatment that successfully lowered his blood pressure to a healthy level for the first time.… Read more
-
Motor neuron disease inflammation trigger discovered
In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,… Read more
-
US President Donald Trump has COVID-19 and is on a cocktail of experimental drugs. What does this mean for his health?
It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.… Read more
-
Key to immune system inflammation discovery
Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.… Read more
-
Medical research to benefit from Morningside Ventures appointment
Australia’s medical research sector will benefit from the appointment of Hudson Institute inflammation scientist Associate Professor Ashley Mansell to global firm Morningside BioPharma Advisory,… Read more